Will Gritstone bio Inc. (GRTS) Report Negative Q3 Earnings? What You Should KnowZacks Investment Research • 10/28/21
Gritstone Announces Presentations during Five Upcoming Investor Conferences and EventsGlobeNewsWire • 10/25/21
Gritstone Announces Dosing of First Volunteer in Trial Evaluating Self-Amplifying mRNA as a COVID-19 Vaccine Booster and Immunogenicity EnhancerGlobeNewsWire • 09/20/21
Gritstone Presents Data From Individualized Neoantigen Immunotherapy In Colorectal CancerBenzinga • 09/17/21
Gritstone Announces Dosing of First Solid Tumor Patient with Optimized SLATE “Off-the-Shelf” Mutant KRAS-directed Neoantigen Immunotherapy in Phase 2 Clinical TrialGlobeNewsWire • 09/17/21
Gritstone Announces Positive Clinical Data with GRANITE (Individualized Neoantigen Immunotherapy Program) during ESMO 2021 and Launch of Randomized Clinical Trial Program in Colorectal Cancer with Registrational IntentGlobeNewsWire • 09/17/21
Gritstone to Host Data Update on Neoantigen Oncology Programs for the Treatment of Solid Tumors During ESMO 2021GlobeNewsWire • 09/09/21
Gritstone bio Inc. (GRTS) is a Great Momentum Stock: Should You Buy?Zacks Investment Research • 09/09/21
Gritsone Bio Secures CEPI Funding For Its Differentiated COVID-19 Vaccine CandidateBenzinga • 08/17/21
Gritstone bio Inc. (GRTS) Reports Q2 Loss, Lags Revenue EstimatesZacks Investment Research • 08/05/21
Will Gritstone bio Inc. (GRTS) Report Negative Q2 Earnings? What You Should KnowZacks Investment Research • 07/28/21
Gritstone Announces Management Changes, Including the Appointment of Celia Economides as Chief Financial OfficerGlobeNewsWire • 06/23/21
Gritstone Oncology, Inc. (GRTS) Q1 Earnings and Revenues Top EstimatesZacks Investment Research • 05/06/21
Gritstone Reports First Quarter 2021 Financial Results and Business HighlightsGlobeNewsWire • 05/06/21
Gritstone Oncology Changes its Name to Gritstone bio to Reflect Expanded Therapeutic FocusGlobeNewsWire • 05/03/21